RHUMBLINE ADVISERS - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 146 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,793,412
+8.0%
87,527
+4.7%
0.00%0.0%
Q2 2023$1,660,357
+104985.9%
83,561
-9.4%
0.00%0.0%
Q1 2023$1,580
-5.2%
92,222
+8.3%
0.00%0.0%
Q4 2022$1,667
-99.9%
85,192
+21.3%
0.00%0.0%
Q3 2022$1,121,000
+22.9%
70,256
+6.0%
0.00%
+100.0%
Q2 2022$912,000
+28.8%
66,295
+48.5%
0.00%0.0%
Q1 2022$708,000
-24.7%
44,652
+3.7%
0.00%0.0%
Q4 2021$940,000
-29.2%
43,077
-3.0%
0.00%
-50.0%
Q3 2021$1,327,000
-29.8%
44,396
+4.0%
0.00%0.0%
Q2 2021$1,890,000
-0.8%
42,684
-0.6%
0.00%
-33.3%
Q1 2021$1,905,000
-24.4%
42,939
-6.5%
0.00%0.0%
Q4 2020$2,519,000
+142.0%
45,940
+0.9%
0.00%
+50.0%
Q3 2020$1,041,000
-3.4%
45,533
-11.6%
0.00%0.0%
Q2 2020$1,078,000
+96.0%
51,483
+30.5%
0.00%
+100.0%
Q1 2020$550,000
-35.5%
39,442
+5.2%
0.00%0.0%
Q4 2019$853,000
+98.8%
37,493
+1.8%
0.00%0.0%
Q3 2019$429,000
-22.6%
36,823
-0.4%
0.00%0.0%
Q2 2019$554,000
+3.0%
36,963
+20.4%
0.00%0.0%
Q1 2019$538,000
+29.0%
30,695
+9.1%
0.00%0.0%
Q4 2018$417,000
-11.3%
28,122
+47.3%
0.00%0.0%
Q3 2018$470,000
+18.1%
19,086
-5.9%
0.00%0.0%
Q2 2018$398,00020,2870.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 715,880$9,851,00011.04%
RTW INVESTMENTS, LP 15,802,802$217,447,0005.62%
Amitell Capital Pte Ltd 97,331$1,339,0003.05%
Prosight Management, LP 276,802$3,809,0003.00%
TANG CAPITAL MANAGEMENT LLC 1,265,900$17,419,0002.64%
Affinity Asset Advisors, LLC 250,466$3,446,0001.45%
COWEN AND COMPANY, LLC 1,000,000$13,760,0001.33%
Boxer Capital, LLC 1,466,051$20,173,0001.28%
Cormorant Asset Management, LP 868,550$11,951,0000.90%
MAVERICK CAPITAL LTD 2,532,366$34,845,0000.86%
View complete list of ROCKET PHARMACEUTICALS INC shareholders